Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Tomoyoshi Miyamoto"'
Autor:
Shiori Iwane, Wataru Nemoto, Tomoyoshi Miyamoto, Tomonori Hayashi, Masayuki Tanaka, Kazuki Uchitani, Tatsuya Muranaka, Masanori Fujitani, Yuichi Koizumi, Atsushi Hirata, Maho Tsubota, Fumiko Sekiguchi, Koichi Tan-No, Atsufumi Kawabata
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Given possible involvement of the central and peripheral angiotensin system in pain processing, we conducted clinical and preclinical studies to test whether pharmacological inhibition of the angiotensin system would prevent diabetic periphe
Externí odkaz:
https://doaj.org/article/870869dc706643ddbf7385bad4356947
Autor:
Tomoyoshi Miyamoto, Risa Domoto, Fumiko Sekiguchi, Riki Kamaguchi, Rika Nishimura, Misato Matsuno, Maho Tsubota, Masanori Fujitani, Shigekatsu Hatanaka, Yuichi Koizumi, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 3, Pp 315-325 (2022)
Oxaliplatin often induces peripheral neuropathy, a dose-limiting adverse reaction, and in rare cases leads to sinusoidal obstruction syndrome. We thus conducted a retrospective cohort study to examine the relationship between oxaliplatin-induced peri
Externí odkaz:
https://doaj.org/article/ae80f6ce76474753aac680a6bbaefe92
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract To identify risk factors for the prognosis of prostate cancer (PC), we retrospectively analyzed the impact of lifestyle-related disorders as well as PC characteristics at initial diagnosis on the progression to castration-resistant PC (CRPC)
Externí odkaz:
https://doaj.org/article/9be7617cad6749498196df2c4e85778a
Autor:
Tomoyoshi Miyamoto, Shiori Hiramoto, Ayano Kanto, Maho Tsubota, Masanori Fujitani, Hiroki Fukuyama, Shigekatsu Hatanaka, Fumiko Sekiguchi, Yuichi Koizumi, Atsufumi Kawabata
Publikováno v:
Journal of Pharmacological Sciences, Vol 146, Iss 1, Pp 49-57 (2021)
We performed clinical retrospective study in female cancer patients and fundamental experiments in mice, in order to clarify risk factors for paclitaxel-induced peripheral neuropathy (PIPN). In the clinical study, 131 of 189 female outpatients with c
Externí odkaz:
https://doaj.org/article/662ea1d38ff745348f0639e0bdd40cfa
Publikováno v:
PLoS ONE, Vol 16, Iss 12 (2021)
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake i
Externí odkaz:
https://doaj.org/article/ecb7df462d8f40d7a462c33518a07e60
Autor:
Shigekatsu Hatanaka, Ayano Kanto, Masanori Fujitani, Atsufumi Kawabata, Hiroki Fukuyama, Maho Tsubota, Shiori Hiramoto, Fumiko Sekiguchi, Yuichi Koizumi, Tomoyoshi Miyamoto
Publikováno v:
Journal of Pharmacological Sciences, Vol 146, Iss 1, Pp 49-57 (2021)
We performed clinical retrospective study in female cancer patients and fundamental experiments in mice, in order to clarify risk factors for paclitaxel-induced peripheral neuropathy (PIPN). In the clinical study, 131 of 189 female outpatients with c
Autor:
Tomoyoshi Miyamoto, Risa Domoto, Fumiko Sekiguchi, Riki Kamaguchi, Rika Nishimura, Misato Matsuno, Maho Tsubota, Masanori Fujitani, Shigekatsu Hatanaka, Yuichi Koizumi, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 3, Pp 315-325 (2022)
Oxaliplatin often induces peripheral neuropathy, a dose-limiting adverse reaction, and in rare cases leads to sinusoidal obstruction syndrome. We thus conducted a retrospective cohort study to examine the relationship between oxaliplatin-induced peri
Publikováno v:
Journal of palliative medicine. 25(4)
Background: Accurate prognosis in terminal cancer patients is useful to improve their quality of life and also to decide the cessation of fluid administration. Nonetheless, few prognostic indicator...
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
To identify risk factors for the prognosis of prostate cancer (PC), we retrospectively analyzed the impact of lifestyle-related disorders as well as PC characteristics at initial diagnosis on the progression to castration-resistant PC (CRPC) in PC pa
Autor:
Yuki Nishii, Hiroki Fukuyama, Masanori Fujitani, Mitsuko Okiyama, Yuichi Koizumi, Tomoyoshi Miyamoto, Hiroko Amao, Akiko Kitayama
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 45:208-213